Export 257 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
B. D. Cheson, Wittes, R. E., and Phillips, P. H., Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I., Oncology (Williston Park), vol. 9, no. 4, pp. 292-4, 1995.
B. D. Cheson, Rosenberg, S. A., and Phillips, P. H., Clinical trials referral resource. Clinical trials at the surgery branch of the NCI., Oncology (Williston Park), vol. 9, no. 5, pp. 453-4, 1995.
B. D. Cheson and Nelson, A. P., Clinical trials referral resource. Clinical trials in adult acute myelogenous leukemia., Oncology (Williston Park), vol. 12, no. 2, p. 224, 227, 1998.
B. D. Cheson, Wilson, W. H., and Phillips, P. H., Clinical trials at the medicine branch of the NCI-part 2., Oncology (Williston Park), vol. 9, no. 6, pp. 506, 509-10, 1995.
B. D. Cheson, Phillips, P. H., and Sznol, M., Clinical Trials Referral Resource. Trials using tumor vaccines., Oncology (Williston Park), vol. 11, no. 1, pp. 81-2, 84, 90, 1997.
E. Y. Chew, Lindblad, A. S., and Clemons, T., Summary results and recommendations from the age-related eye disease study., Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
E. Y. Chew, Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., Singerman, L., Schwartz, S. D., Peachey, N. S., and Bird, A. C., Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial., Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
E. Y. Chew and Clemons, T. E., Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply., JAMA Ophthalmol, vol. 132, no. 7, pp. 904-5, 2014.
E. Y. Chew, Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., Singerman, L., Schwartz, S. D., Peachey, N. S., and Bird, A. C., Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial, Am J Ophthalmol, vol. 159, pp. 659-666.e1., 2015.
E. Y. Chew, Kim, J., Sperduto, R. D., Datiles, M. B., Coleman, H. R., Thompson, D. J. S., Milton, R. C., Clayton, J. A., Hubbard, L. D., Danis, R. P., and Ferris, F. L., Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31., Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Kurinij, N., Davis, M. D., and AREDS), A. - R. Eye Diseas, Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35, Opthalmology, vol. 120, pp. 1604-1611e.4, 2013.
E. Y. Chew, Ferris, F. L., Csaky, K. G., Murphy, R. P., Agrón, E., Thompson, D. J. S., Reed, G. F., and Schachat, A. P., The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study., Ophthalmology, vol. 110, no. 9, pp. 1683-9, 2003.
E. Chew, Klein, M. L., Clemons, T., Agron, E., Ratnapriya, R., Edwards, A., Fritsche, L., Swaroop, A., Abecasis, G., and Group, T. Age Relate, No Clinically Significant Association Between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38, Ophthalmology, vol. 121, pp. 2173-2180, 2014.
E. Y. Chew, Clemons, T. E., Agron, E., Sperduto, R. D., SanGiovanni, J. P., Davis, M. D., 3rd, F. L. Ferris, and AREDS), T. Age- Relate, Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
E. Y. Chew, Kim, J., Coleman, H. R., Aiello, L. Paul, Fish, G., Ip, M., Haller, J. A., Figueroa, M., Martin, D., Callanan, D., Avery, R., Hammel, K., Thompson, D. J. S., and Ferris, F. L., Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema., Retina, vol. 30, no. 3, pp. 459-67, 2010.
E. Y. Chew, Klein, M. L., Clemons, T. E., Agrón, E., Ratnapriya, R., Edwards, A. O., Fritsche, L. G., Swaroop, A., and Abecasis, G. R., No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38., Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
E. Y. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., Garfinkel, R. A., and Group, A. 1 for A. R. E. D., Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1, Contemporary Clinical Trials, vol. 37, pp. 294-300, 2014.
E. Chew, Kim, J., Coleman, H., Aiello, L., Fish, G., Ip, M., Haller, J., Figueroa, M., Martin, D., Callanan, D., Avery, R., Hammel, K., Thompson, D., and , Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema, Retina, vol. 30, pp. 459-467, 2010.
E. Y. Chew, Clemons, T. E., Bressler, S., Klein, M., Ruby, A., Seddon, J., and Group, A. - R. Eye Diseas, Serum Nutrient Levels as Risk Factors for Neovascular AMD, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
E. Chew, Clemons, T., Milton, R. C., Davis, M. D., Ferris, III, F. L., and Group, A. - R. Eye Diseas, Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
E. Y. Chew and Clemons, T. E. ;, Experimental Design Issues for Assessment of Carotenoids Lutein and Zeaxanthin in Age-Related Eye Disease Study 2 Formulation for Age-Related Macular Degeneration, JAMA Ophthalmol, vol. 132, pp. 904-905, 2014.
E. Chew, III, F. L. Ferris, Lindley, A., Hoogwerth, B., Wu, L., and Group, theE. T. D. R. S. Stud, Association of renal disease with diabetic retinopathy and other risk factors, 1999.
E. Chew, SanGiovanni, J. P., Clemons, T., Harrington, M., and McBee, W., Association of Cognitive Function and Depression with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2), in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
E. Y. Chew, Clemons, T. E., Jaffe, G. J., Johnson, C. A., Farsiu, S., Lad, E. M., Guymer, R., Rosenfeld, P., Hubschman, J. - P., Constable, I., Wiley, H., Singerman, L. J., Gillies, M., Comer, G., Blodi, B., Eliott, D., Yan, J., Bird, A., and Friedlander, M., Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial., Ophthalmology, vol. 126, no. 4, pp. 540-549, 2019.
E. Y. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R. A., Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1., Contemp Clin Trials, vol. 37, no. 2, pp. 294-300, 2014.